-
EP1117658
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1117658
| EP1117658 - 1,3-BENZODIAZEPINES WITH INTEGRIN INHIBITORY ACTIVITY FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.05.2005 Database last updated on 29.10.2024 | Most recent event Tooltip | 13.05.2005 | Application deemed to be withdrawn | published on 29.06.2005 [2005/26] | Applicant(s) | For all designated states CELLTECH THERAPEUTICS LIMITED 208 Bath Road Slough Berkshire SL1 3WE / GB | [N/P] |
| Former [2001/30] | For all designated states CELLTECH THERAPEUTICS LIMITED 216 Bath Road Slough, Berkshire SL1 4EN / GB | Inventor(s) | 01 /
BROWN, Julien, Alistair 19 Blackthorn Close, Earley Reading, Berkshire RG6 1DH / GB | 02 /
WARRELLOW, Graham, John Oakside, 4 Wieland Road Northwood, Middlesex HA6 3QU / GB | 03 /
PORTER, John, Robert 5 Farm Place, Henton Chinnor, Oxfordshire OX9 4AD / GB | 04 /
ARCHIBALD, Sarah, Catherine 5 College Glen Maidenhead, Berkshire SL6 6BL / GB | 05 /
HEAD, John, Clifford 4 Dorchester Close Maidenhead, Berkshire SL6 6RX / GB | [2001/30] | Representative(s) | Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2001/30] | Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 99947704.5 | 30.09.1999 | [2001/30] | WO1999GB03239 | Priority number, date | GB19980021222 | 30.09.1998 Original published format: GB 9821222 | [2001/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0018760 | Date: | 06.04.2000 | Language: | EN | [2000/14] | Type: | A1 Application with search report | No.: | EP1117658 | Date: | 25.07.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.04.2000 takes the place of the publication of the European patent application. | [2001/30] | Search report(s) | International search report - published on: | EP | 06.04.2000 | Classification | IPC: | C07D401/12, A61K31/435, A61K31/4427 | [2001/30] | CPC: |
C07D401/14 (EP,US);
A61P1/00 (EP);
A61P11/06 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/30] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | 1,3-BENZODIAZEPINE MIT INTEGRIN INHIBIERENDER WIRKUNG ZUR VERWENDUNG BEI DER BEHANDLUNG ENTZÜNDLICHER PROZESSE | [2001/30] | English: | 1,3-BENZODIAZEPINES WITH INTEGRIN INHIBITORY ACTIVITY FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS | [2001/30] | French: | 1,3-BENZODIAZEPINES POSSEDANT UNE ACTIVITE INHIBANT L'INTEGRINE UTILES POUR TRAITER DES TROUBLES INFLAMMATOIRES | [2001/30] | Entry into regional phase | 19.04.2001 | National basic fee paid | 19.04.2001 | Designation fee(s) paid | 19.04.2001 | Examination fee paid | Examination procedure | 26.04.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 19.04.2001 | Examination requested [2001/30] | 09.07.2003 | Despatch of a communication from the examining division (Time limit: M04) | 13.11.2003 | Reply to a communication from the examining division | 10.02.2004 | Despatch of a communication from the examining division (Time limit: M04) | 04.06.2004 | Reply to a communication from the examining division | 13.08.2004 | Communication of intention to grant the patent | 24.12.2004 | Application deemed to be withdrawn, date of legal effect [2005/26] | 31.01.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2005/26] | Fees paid | Renewal fee | 19.04.2001 | Renewal fee patent year 03 | 12.09.2002 | Renewal fee patent year 04 | 12.09.2003 | Renewal fee patent year 05 | 14.09.2004 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9300095 (SMITHKLINE BEECHAM CORP [US]) [A] 1-8 * column W *; | [A]WO9308174 (GENENTECH INC [US]) [A] 1-8 * column W *; | [A]WO9626190 (SMITHKLINE BEECHAM CORP [US], et al) [A] 1-8 * column W *; | [A] - VENTURELLA,V.S. ET AL., "Substituted 1,3-dihydro-4H-furo[3,4-d]-1,3-benzodiazepin-3-ones : Synthesis and scope of method", J.HETEROCYCLIC.CHEM., ALBUQUERQUE, (1969), vol. 6, no. 5, pages 671 - 679, XP002128238 [A] 1-8 * column W * DOI: http://dx.doi.org/10.1002/jhet.5570060514 | [A] - MILLER W H ET AL, "Structure-activity relationships in 3-oxo-1,4-benzodiazepine-2-acetic acid GPIIb/IIIa antagonists. The 2-benzazepine series", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD, (1996), vol. 6, no. 21, ISSN 0960-894X, page 2481-2486, XP004135899 [A] 1-8 * column W * DOI: http://dx.doi.org/10.1016/0960-894X(96)00432-5 | [A] - MCDOWELL R S ET AL, "FROM PEPTIDE TO NON-PEPTIDE. THE DE NOVO DESIGN OF POTENT, NON- PEPTIDAL INHIBITORS OF PLATELET AGGREGATION BASED ON A BENZODIAZEPINEDIONE SCAFFOLD", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,US,AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, (1994), vol. 116, no. 12, ISSN 0002-7863, page 5077-5083, XP002069808 [A] 1-8 * column W * DOI: http://dx.doi.org/10.1021/ja00091a008 | [A] - KEENAN,R.M. ET AL., "Discovery of Potent Nonpeptide Vitronectin Receptor Antagonists", J.MED.CHEM., WASHINGTON, (19970718), vol. 40, no. 15, pages 2289 - 2292, XP002128454 [A] 1-8 * column W * DOI: http://dx.doi.org/10.1021/jm970205r |